Cognetivity Neurosciences (1UB) Financial Statements
Cognetivity Neurosciences Financial Overview
Cognetivity Neurosciences's market cap is currently $572.39K. The company's EPS TTM is $-0.10; its P/E ratio is -0.13; Cognetivity Neurosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Apr 22 | Apr 21 | Apr 20 | Jan 20 | Jan 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 45.37K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.13M | $ -24.53K | $ -11.45K | $ -9.29K | $ -3.94K |
| Operating Income | $ -6.29M | $ -13.04M | $ -2.39M | $ -2.60M | $ -4.21M |
| EBITDA | $ -6.38M | $ -13.01M | $ -2.39M | $ -2.60M | $ -4.21M |
| Net Income | $ -7.43M | $ -13.13M | $ -1.93M | $ -2.65M | $ -4.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.24M | $ 1.38M | $ 1.36M | $ 578.23K | $ 378.75K |
| Total Assets | $ 2.83M | $ 2.00M | $ 1.83M | $ 748.07K | $ 716.32K |
| Total Debt | $ 1.29M | $ 1.29M | $ 313.66K | $ 307.01K | $ 0.00 |
| Net Debt | $ -953.42K | $ -82.43K | $ -1.05M | $ -271.22K | $ -250.75K |
| Total Liabilities | $ 12.72M | $ 7.68M | $ 964.89K | $ 1.01M | $ 236.91K |
| Stockholders' Equity | $ -9.89M | $ -5.68M | $ 862.91K | $ -263.04K | $ 479.41K |
| Cash Flow | |||||
| Free Cash Flow | $ -6.01M | $ -3.31M | $ -2.01M | $ -1.88M | $ -3.51M |
| Operating Cash Flow | $ -5.94M | $ -3.21M | $ -1.96M | $ -1.86M | $ -3.49M |
| Investing Cash Flow | $ -69.69K | $ -100.01K | $ -50.08K | $ 106.18K | $ 3.32M |
| Financing Cash Flow | $ 6.88M | $ 3.33M | $ 2.79M | $ 2.08M | $ 298.75K |
Currency in CAD
